Compile Data Set for Download or QSAR
Report error Found 33 Enz. Inhib. hit(s) with all data for entry = 12678
TargetD(3) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707643(US12168007, Example 1 | US20250049786, Example 1)
Affinity DataKi:  0.100nMAssay Description:Aliquoted membrane preparations were incubated with 0.7 nM [3H]spiperone (PerkinElmer) in the presence or absence of test compound in 96-well plates ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(3) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM50631876(CHEMBL5433284 | US20250049786, Reference Example 2)
Affinity DataKi:  0.158nMAssay Description:Aliquoted membrane preparations were incubated with 0.7 nM [3H]spiperone (PerkinElmer) in the presence or absence of test compound in 96-well plates ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(3) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707644(US12168007, Example 2 | US20250049786, Example 2)
Affinity DataKi:  0.170nMAssay Description:Aliquoted membrane preparations were incubated with 0.7 nM [3H]spiperone (PerkinElmer) in the presence or absence of test compound in 96-well plates ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(3) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707645(US12168007, Example 3 | US20250049786, Example 3)
Affinity DataKi:  0.182nMAssay Description:Aliquoted membrane preparations were incubated with 0.7 nM [3H]spiperone (PerkinElmer) in the presence or absence of test compound in 96-well plates ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(3) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM50631876(CHEMBL5433284 | US20250049786, Reference Example 2)
Affinity DataKi:  0.309nMAssay Description:Compounds were diluted in DMSO and binding buffer (containing 50 mM Tris, 5 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 120 mM NaCl, 1 mM EDTA) and 50 μL of each...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM50631876(CHEMBL5433284 | US20250049786, Reference Example 2)
Affinity DataKi:  0.631nMAssay Description:Aliquoted membrane preparations were incubated with 0.16 nM [3H]spiperone (PerkinElmer) in the presence or absence of test compound in 96-well plates...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(3) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707644(US12168007, Example 2 | US20250049786, Example 2)
Affinity DataKi:  0.708nMAssay Description:Compounds were diluted in DMSO and binding buffer (containing 50 mM Tris, 5 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 120 mM NaCl, 1 mM EDTA) and 50 μL of each...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707644(US12168007, Example 2 | US20250049786, Example 2)
Affinity DataEC50:  0.724nMAssay Description:PathHunter CHO-K1 cells expressing tagged human D2L receptors and tagged β-arrestin-2 (Eurofins DiscoverX, Fremont, CA, USA) were seeded into 96-well...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707643(US12168007, Example 1 | US20250049786, Example 1)
Affinity DataKi:  0.871nMAssay Description:Aliquoted membrane preparations were incubated with 0.16 nM [3H]spiperone (PerkinElmer) in the presence or absence of test compound in 96-well plates...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(3) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707643(US12168007, Example 1 | US20250049786, Example 1)
Affinity DataKi:  1.02nMAssay Description:Compounds were diluted in DMSO and binding buffer (containing 50 mM Tris, 5 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 120 mM NaCl, 1 mM EDTA) and 50 μL of each...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707643(US12168007, Example 1 | US20250049786, Example 1)
Affinity DataEC50:  1.10nMAssay Description:PathHunter CHO-K1 cells expressing tagged human D2L receptors and tagged β-arrestin-2 (Eurofins DiscoverX, Fremont, CA, USA) were seeded into 96-well...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707645(US12168007, Example 3 | US20250049786, Example 3)
Affinity DataKi:  1.15nMAssay Description:Test compounds were diluted serially in DMSO and subsequently diluted to 5% DMSO (v/w) in binding buffer (50 mM Tris, 5 mM MgCl2, 5 mM KCl, 1 mM CaCl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707644(US12168007, Example 2 | US20250049786, Example 2)
Affinity DataKi:  1.17nMAssay Description:Aliquoted membrane preparations were incubated with 0.16 nM [3H]spiperone (PerkinElmer) in the presence or absence of test compound in 96-well plates...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707645(US12168007, Example 3 | US20250049786, Example 3)
Affinity DataKi:  1.17nMAssay Description:Aliquoted membrane preparations were incubated with 0.16 nM [3H]spiperone (PerkinElmer) in the presence or absence of test compound in 96-well plates...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707644(US12168007, Example 2 | US20250049786, Example 2)
Affinity DataKi:  1.26nMAssay Description:Test compounds were diluted serially in DMSO and subsequently diluted to 5% DMSO (v/w) in binding buffer (50 mM Tris, 5 mM MgCl2, 5 mM KCl, 1 mM CaCl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707644(US12168007, Example 2 | US20250049786, Example 2)
Affinity DataEC50:  1.32nMAssay Description:Agonist activity at human D2L receptors was assayed by measuring cAMP levels in CHO-K1 cells expressing human D2L receptors (Eurofins DiscoverX, Frem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(3) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM50631876(CHEMBL5433284 | US20250049786, Reference Example 2)
Affinity DataEC50:  1.95nMAssay Description:Agonist activity at human D3 receptors was assayed by cAMP levels in HEK293 cells expressing recombinant human D3 receptors (BioXtal, Saint-Félix, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(3) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707644(US12168007, Example 2 | US20250049786, Example 2)
Affinity DataEC50:  1.95nMAssay Description:Agonist activity at human D3 receptors was assayed by cAMP levels in HEK293 cells expressing recombinant human D3 receptors (BioXtal, Saint-Félix, Fr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM50631876(CHEMBL5433284 | US20250049786, Reference Example 2)
Affinity DataKi:  1.95nMAssay Description:Test compounds were diluted serially in DMSO and subsequently diluted to 5% DMSO (v/w) in binding buffer (50 mM Tris, 5 mM MgCl2, 5 mM KCl, 1 mM CaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707643(US12168007, Example 1 | US20250049786, Example 1)
Affinity DataKi:  1.95nMAssay Description:Test compounds were diluted serially in DMSO and subsequently diluted to 5% DMSO (v/w) in binding buffer (50 mM Tris, 5 mM MgCl2, 5 mM KCl, 1 mM CaCl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM50631876(CHEMBL5433284 | US20250049786, Reference Example 2)
Affinity DataEC50:  1.95nMAssay Description:PathHunter CHO-K1 cells expressing tagged human D2L receptors and tagged β-arrestin-2 (Eurofins DiscoverX, Fremont, CA, USA) were seeded into 96-well...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(3) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM50631876(CHEMBL5433284 | US20250049786, Reference Example 2)
Affinity DataEC50:  2.82nMAssay Description:PathHunter CHO-K1 cells expressing tagged human D3 receptors and tagged β-arrestin-2 (Eurofins DiscoverX, Fremont, CA, USA) were seeded into 96-well ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(3) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707643(US12168007, Example 1 | US20250049786, Example 1)
Affinity DataEC50:  3.09nMAssay Description:PathHunter CHO-K1 cells expressing tagged human D3 receptors and tagged β-arrestin-2 (Eurofins DiscoverX, Fremont, CA, USA) were seeded into 96-well ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(3) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707643(US12168007, Example 1 | US20250049786, Example 1)
Affinity DataEC50:  3.55nMAssay Description:Agonist activity at human D3 receptors was assayed by cAMP levels in HEK293 cells expressing recombinant human D3 receptors (BioXtal, Saint-Félix, Fr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM50631876(CHEMBL5433284 | US20250049786, Reference Example 2)
Affinity DataEC50:  3.72nMAssay Description:Agonist activity at human D2L receptors was assayed by measuring cAMP levels in CHO-K1 cells expressing human D2L receptors (Eurofins DiscoverX, Frem...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707643(US12168007, Example 1 | US20250049786, Example 1)
Affinity DataEC50:  3.72nMAssay Description:Agonist activity at human D2L receptors was assayed by measuring cAMP levels in CHO-K1 cells expressing human D2L receptors (Eurofins DiscoverX, Frem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

TargetD(3) dopamine receptor(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707644(US12168007, Example 2 | US20250049786, Example 2)
Affinity DataEC50:  3.89nMAssay Description:PathHunter CHO-K1 cells expressing tagged human D3 receptors and tagged β-arrestin-2 (Eurofins DiscoverX, Fremont, CA, USA) were seeded into 96-well ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707644(US12168007, Example 2 | US20250049786, Example 2)
Affinity DataKi:  15.5nMAssay Description:Receptor membranes were prepared from the CHO-K1 recombinant AequoScreen® cell line stably expressing the human 5-HT2A receptor (PerkinElmer, Waltham...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707643(US12168007, Example 1 | US20250049786, Example 1)
Affinity DataKi:  22.9nMAssay Description:Receptor membranes were prepared from the CHO-K1 recombinant AequoScreen® cell line stably expressing the human 5-HT2A receptor (PerkinElmer, Waltham...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Richter Gedeon

US Patent
LigandPNGBDBM50631876(CHEMBL5433284 | US20250049786, Reference Example 2)
Affinity DataKi:  29.5nMAssay Description:Receptor membranes were prepared from the CHO-K1 recombinant AequoScreen® cell line stably expressing the human 5-HT2A receptor (PerkinElmer, Waltham...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707644(US12168007, Example 2 | US20250049786, Example 2)
Affinity DataIC50: 132nMAssay Description:CHO-K1 cells expressing human recombinant 5-HT2A receptors and Gα16 (purchased from Euroscreen Fast, Brussels, BE) in culture were cryopreserved acco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Richter Gedeon

US Patent
LigandPNGBDBM707643(US12168007, Example 1 | US20250049786, Example 1)
Affinity DataIC50: 158nMAssay Description:CHO-K1 cells expressing human recombinant 5-HT2A receptors and Gα16 (purchased from Euroscreen Fast, Brussels, BE) in culture were cryopreserved acco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Richter Gedeon

US Patent
LigandPNGBDBM50631876(CHEMBL5433284 | US20250049786, Reference Example 2)
Affinity DataIC50: 178nMAssay Description:CHO-K1 cells expressing human recombinant 5-HT2A receptors and Gα16 (purchased from Euroscreen Fast, Brussels, BE) in culture were cryopreserved acco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/16/2025
Entry Details
Go to US Patent